Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 10/20 | 0.51 |
| ▸ | RORC | P51449 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13894369 | 0.87 | PTGER1 (0.57) | PTGER1RORCALDH1A1LMNAHPGD | |
| SCHEMBL12487408 | 0.87 | PTGER1 (0.57) | PTGER1RORCALDH1A1LMNAHPGD | |
| SCHEMBL12407713 | 0.86 | PTGER1 (0.51) | PTGER1RORCALDH1A1LMNAHPGD | |
| SCHEMBL12481864 | 0.85 | PTGER1 (0.59) | PTGER1RORCTHRB | |
| SCHEMBL13894479 | 0.84 | LMNA (0.62) | PTGER1RORCALDH1A1LMNAHPGD | |
| SCHEMBL12482285 | 0.83 | PTGER1 (0.62) | PTGER1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL12484938 | 0.81 | RORC (0.59) | PTGER1RORCALDH1A1LMNAHPGD | |
| SCHEMBL13894303 | 0.81 | RORC (0.54) | PTGER1RORCALDH1A1LMNAHPGD | |
| SCHEMBL12481964 | 0.81 | RORC (0.61) | PTGER1RORCALDH1A1LMNAHPGD | |
| SCHEMBL13894483 | 0.81 | PTGER1 (0.66) | PTGER1RORCALDH1A1LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2050446-A1 | SULFONAMIDE COMPOUND OR SALT THEREOF | Astellas Pharma Inc. (JP) | 2009-04-22 | — | — | EP | disclosed |